docetaxel anhydrous has been researched along with Genetic Predisposition in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 13 (81.25) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Cong, Z; Guo, L; Huai, C; Jia, L; Li, G; Li, M; Liu, Y; Ma, J; Niu, X; Qin, S; Ren, W; Shen, L; Su, K; Sun, X; Zhang, D; Zhang, S; Zhou, C; Zhou, W | 1 |
| Bermejo, B; de la Torre-Montero, JC; Del Monte-Millán, M; García-Sáenz, JÁ; González-Neira, A; Herraez, B; Lluch, A; Martín, M; Núñez-Torres, R; Peiró-Chova, L; Pinilla, K; Pita, G; Rodrigo-Faus, M; Tejera-Pérez, H | 1 |
| Churchill, GA; Gatti, DM; Goodwin, NC; Lammert, F; Weber, SN | 1 |
| Behera, D; Sharma, S; Singh, A; Singh, N | 1 |
| do Brasil Costa, VI; Jorge, RV; Nobre, FF; Paula, DP | 1 |
| Awada, Z; Bazarbachi, A; El-Saghir, NS; Haider, S; Salem, Z; Shamseddine, A; Taher, A; Tfayli, A; Zgheib, NK | 1 |
| Akin, S; Al-Batran, SE; Ehninger, G; Goekkurt, E; Heussen, N; Hofheinz, RD; Kramer, M; Lehmann, S; Pauligk, C; Senff, T; Stenholm, L; Stoehlmacher-Williams, J | 1 |
| Antonarakis, ES; Carducci, MA; Chen, Y; Denmeade, SR; Eisenberger, MA; Lu, C; Luber, B; Luo, J; Nadal, R; Nakazawa, M; Paller, CJ; Wang, H | 1 |
| Brown, R; Glass, S; He, YJ; Hoskins, JM; McLeod, HL; Motsinger-Reif, A; Paul, J; Winham, SJ | 1 |
| de Bruijn, P; de Graan, AM; de Wit, R; Elbouazzaoui, S; Eskens, FA; Hamberg, P; Martens, JW; Mathijssen, RH; Nieuweboer, AJ; Smid, M; Sparreboom, A; van Schaik, RH | 1 |
| Acharyya, S; Bilger, M; Haaland, B; Lopes, G; Tan, PS | 1 |
| Beijnen, JH; Boot, H; Cats, A; Deenen, MJ; Legdeur, MC; Meulendijks, D; Schellens, JH | 1 |
| Del Monte-Millán, M; Fuentes, H; García-Saenz, JA; Gómez, H; González-Rivera, M; Jerez, Y; Lobo, M; López-Tarruella, S; Márquez-Rodas, I; Martin, M; Massarrah, T; Moreno, F; Ocaña, I; Pérez-Carbornero, L; Picornell, A; Ramos-Medina, R; Santillán Garzón, S | 1 |
| Carducci, MA; Dolan, ME; Dorsey, SG; Febbo, PG; Friedman, PN; Furukawa, Y; Halabi, S; Hertz, DL; Jiang, C; Kelley, MJ; Kelly, WK; Krens, SD; Kroetz, DL; Kubo, M; Lassiter, C; Lessans, S; Mahoney, JF; McLeod, HL; Morris, MJ; Mulkey, F; Nakamura, Y; Owzar, K; Patel, J; Ratain, MJ; Renn, CL; Shterev, I; Sibley, AB; Small, EJ; Watson, D; Weisman, L; Wheeler, HE; Wing, C | 1 |
| Baricordi, OR; Ferlini, A; Indelli, M; Lelli, G; Rimessi, P; Rizzo, R; Spaggiari, F | 1 |
| Beisswanger, E; Buyko, E; Hahn, U | 1 |
1 review(s) available for docetaxel anhydrous and Genetic Predisposition
| Article | Year |
|---|---|
Bayesian network meta-comparison of maintenance treatments for stage IIIb/IV non-small-cell lung cancer (NSCLC) patients with good performance status not progressing after first-line induction chemotherapy: results by performance status, EGFR mutation, hi
Topics: Antineoplastic Agents; Bayes Theorem; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Disease Progression; Disease-Free Survival; Docetaxel; Drug Substitution; ErbB Receptors; Gemcitabine; Genetic Predisposition to Disease; Humans; Induction Chemotherapy; Lung Neoplasms; Maintenance Chemotherapy; Markov Chains; Monte Carlo Method; Mutation; Neoplasm Staging; Pemetrexed; Phenotype; Protein Kinase Inhibitors; Risk Factors; Survival Analysis; Taxoids; Time Factors; Treatment Outcome | 2015 |
3 trial(s) available for docetaxel anhydrous and Genetic Predisposition
| Article | Year |
|---|---|
Carboplatin/taxane-induced gastrointestinal toxicity: a pharmacogenomics study on the SCOTROC1 trial.
Topics: Adenosine Triphosphatases; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cation Transport Proteins; Copper-Transporting ATPases; Docetaxel; Female; Gastrointestinal Diseases; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Kaplan-Meier Estimate; NAV1.8 Voltage-Gated Sodium Channel; Ovarian Neoplasms; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Polymorphism, Single Nucleotide; Proportional Hazards Models; Risk Factors; Scotland; Severity of Illness Index; Taxoids; Time Factors; Treatment Outcome; Vascular Endothelial Growth Factor A | 2016 |
Phase 1a/1b and pharmacogenetic study of docetaxel, oxaliplatin and capecitabine in patients with advanced cancer of the stomach or the gastroesophageal junction.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capecitabine; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Esophagogastric Junction; Fatigue; Female; Genetic Predisposition to Disease; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nausea; Organoplatinum Compounds; Oxaliplatin; Pharmacogenetics; Polymorphism, Single Nucleotide; Stomach Neoplasms; Taxoids; Treatment Outcome | 2015 |
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Docetaxel; Double-Blind Method; Genetic Predisposition to Disease; Genome-Wide Association Study; Genotype; Humans; Intracellular Signaling Peptides and Proteins; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Pharmacogenomic Testing; Polymorphism, Single Nucleotide; Polyneuropathies; Prednisone; Prostatic Neoplasms, Castration-Resistant; Taxoids | 2016 |
12 other study(ies) available for docetaxel anhydrous and Genetic Predisposition
| Article | Year |
|---|---|
Genetic associations of docetaxel-based chemotherapy-induced myelosuppression in Chinese Han population.
Topics: Aged; Antineoplastic Agents; Asian People; Biomarkers; Bone Marrow; Docetaxel; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Neoplasms; Polymorphism, Single Nucleotide | 2020 |
Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer.
Topics: Adult; Age Factors; Alopecia; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B; Biopsy; Breast Neoplasms; Case-Control Studies; Docetaxel; Dose-Response Relationship, Drug; Enhancer Elements, Genetic; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genome-Wide Association Study; Hair Follicle; Humans; Middle Aged; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Retrospective Studies; Risk Factors | 2020 |
Genetic background influences susceptibility to chemotherapy-induced hematotoxicity.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Docetaxel; Doxorubicin; Female; Genetic Background; Genetic Predisposition to Disease; Hematologic Diseases; Humans; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Inbred NOD; Random Allocation | 2018 |
Role of polymorphic XRCC6 (Ku70)/XRCC7 (DNA-PKcs) genes towards susceptibility and prognosis of lung cancer patients undergoing platinum based doublet chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Case-Control Studies; Cisplatin; DNA Breaks, Double-Stranded; DNA-Activated Protein Kinase; DNA, Neoplasm; Docetaxel; Female; Genetic Predisposition to Disease; Humans; Kaplan-Meier Estimate; Ku Autoantigen; Lung Neoplasms; Male; Middle Aged; Nuclear Proteins; Pemetrexed; Polymorphism, Single Nucleotide; Prognosis; Risk Factors; Small Cell Lung Carcinoma; Taxoids | 2018 |
Impact of protocol change on individual factors related to course of adverse reactions to chemotherapy for breast cancer.
Topics: Abdominal Pain; Adult; Aged; Alcohol Oxidoreductases; Antineoplastic Combined Chemotherapy Protocols; Brazil; Breast Neoplasms; Cohort Studies; Cyclophosphamide; Cytochrome P-450 CYP2B6; Diarrhea; Docetaxel; Doxorubicin; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Female; Fluorouracil; Genetic Predisposition to Disease; Humans; Longitudinal Studies; Middle Aged; Pharmacogenomic Testing; Polymorphism, Single Nucleotide | 2020 |
Pharmacogenomics variation in drug metabolizing enzymes and transporters in relation to docetaxel toxicity in Lebanese breast cancer patients: paving the way for OMICs in low and middle income countries.
Topics: Antibodies, Monoclonal, Humanized; Breast Neoplasms; Case-Control Studies; Chemotherapy-Induced Febrile Neutropenia; Docetaxel; Female; Genetic Predisposition to Disease; Genotype; Global Health; Humans; Inactivation, Metabolic; Lebanon; Middle Aged; Pharmacogenetics; Polymorphism, Single Nucleotide; Poverty; Taxoids; Trastuzumab | 2013 |
Prognostic role of microRNA polymorphisms in advanced gastric cancer: a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Female; Fluorouracil; Genetic Predisposition to Disease; Genotype; Humans; Leucovorin; Male; MicroRNAs; Middle Aged; Organoplatinum Compounds; Oxaliplatin; Polymorphism, Single Nucleotide; Prognosis; Stomach Neoplasms; Survival; Taxoids; Vitamin B Complex; Young Adult | 2013 |
Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer.
Topics: Academic Medical Centers; Adenocarcinoma; Aged; Aged, 80 and over; Androstenes; Antineoplastic Agents; Baltimore; Benzamides; Biomarkers, Tumor; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Genetic Predisposition to Disease; Humans; Kallikreins; Kaplan-Meier Estimate; Male; Middle Aged; Neoplastic Cells, Circulating; Nitriles; Patient Selection; Phenotype; Phenylthiohydantoin; Predictive Value of Tests; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Receptors, Androgen; Risk Factors; RNA, Messenger; Taxoids; Time Factors; Treatment Outcome | 2015 |
Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Databases, Genetic; Docetaxel; Female; Genetic Predisposition to Disease; Humans; Inactivation, Metabolic; Male; Membrane Transport Proteins; Metabolic Clearance Rate; Middle Aged; Models, Genetic; Neutropenia; Pharmacogenetics; Pharmacogenomic Variants; Phenotype; Polymorphism, Single Nucleotide; Risk Factors; Severity of Illness Index; Taxoids; Young Adult | 2016 |
Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial.
Topics: Adult; BRCA1 Protein; BRCA2 Protein; Carboplatin; Clinical Trials as Topic; Docetaxel; Female; Genetic Predisposition to Disease; Germ-Line Mutation; Humans; Middle Aged; Neoadjuvant Therapy; Prospective Studies; Taxoids; Triple Negative Breast Neoplasms; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases | 2016 |
Association of CYP1B1 with hypersensitivity induced by taxane therapy in breast cancer patients.
Topics: Aged; Antineoplastic Agents, Phytogenic; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Breast Neoplasms, Male; Chemotherapy, Adjuvant; Chi-Square Distribution; Cytochrome P-450 CYP1B1; Cytochrome P-450 CYP2C8; Cytochrome P-450 Enzyme System; Docetaxel; Drug Hypersensitivity; Female; Gene Frequency; Genetic Predisposition to Disease; Humans; Italy; Logistic Models; Male; Middle Aged; Neoadjuvant Therapy; Odds Ratio; Paclitaxel; Phenotype; Polymorphism, Single Nucleotide; Retrospective Studies; Risk Assessment; Risk Factors; Taxoids; Treatment Outcome | 2010 |
The extraction of pharmacogenetic and pharmacogenomic relations--a case study using PharmGKB.
Topics: Aryl Hydrocarbon Hydroxylases; Breast Neoplasms; Citalopram; Computational Biology; Cytochrome P-450 CYP2C19; Databases, Factual; Databases, Genetic; Docetaxel; Female; Genes, BRCA2; Genetic Predisposition to Disease; Humans; Knowledge Bases; Obesity; Pharmacogenetics; Pharmacokinetics; Protein Interaction Mapping; Taxoids; Urocortins | 2012 |